Experimental simvastatin-induced myopathy in rabbits

J Neurol Sci. 1992 Nov;113(1):114-7. doi: 10.1016/0022-510x(92)90273-n.

Abstract

We induced experimental myopathy in rabbits by giving simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor. After oral administration of simvastatin (50 mg/kg/day) for 2 weeks, serum CK was elevated in 5 of 7 rabbits; degenerating or necrotic fibers were seen in 3 rabbits. Using electromyography, myotonic discharges were found in the 2 rabbits examined. The combination of myotonic discharges, necrosis and raised serum CK levels suggests that the myopathy was induced by lesions of the muscle surface membrane.

MeSH terms

  • Administration, Oral
  • Animals
  • Electromyography
  • Enzymes / blood
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids / blood
  • Lovastatin / analogs & derivatives*
  • Male
  • Muscles / pathology
  • Muscles / physiopathology
  • Muscular Diseases / blood
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / pathology
  • Rabbits
  • Simvastatin

Substances

  • Enzymes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • Lovastatin
  • Simvastatin